# Parkervision Inc: Form 10-Q for the period ended Sep 30, 2020

- Company: [Parkervision Inc](/companies/prkr.md) (CIK 914139)
- Form: 10-Q
- Filed: 2020-11-16
- Accepted by EDGAR: Nov 16, 2020, 16:10 ET
- Period: 2020-09-30
- Accession: 0000914139-20-000071
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/914139/000091413920000071/prkr-20200930x10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/914139/000091413920000071/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Selling, general and administrative | 3 months, 2020-07-01 to 2020-09-30 | $1.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2020-01-01 to 2020-09-30 | $9.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 3 months, 2020-07-01 to 2020-09-30 | $119.0k | us-gaap:InterestExpense |
| Interest expense | 9 months, 2020-01-01 to 2020-09-30 | $420.0k | us-gaap:InterestExpense |
| Net income | 3 months, 2020-07-01 to 2020-09-30 | −$1.7m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2020-01-01 to 2020-09-30 | −$13.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2020-07-01 to 2020-09-30 | −$0.03 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 9 months, 2020-01-01 to 2020-09-30 | −$0.29 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 9 months, 2020-01-01 to 2020-09-30 | −$4.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2020-01-01 to 2020-09-30 | $3.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2020-09-30 | $147.0k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2020-09-30 | $815.0k | us-gaap:AssetsCurrent |
| Total assets | at 2020-09-30 | $3.2m | us-gaap:Assets |
| Current liabilities | at 2020-09-30 | $5.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2020-09-30 | $42.3m | us-gaap:Liabilities |
| Shareholders' equity | at 2020-09-30 | −$39.1m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 19,213 characters.

#### Forward-Looking Statements

We believe that it is important to communicate our future expectations to our shareholders and to the public. This quarterly report contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, including, in particular, statements about our future plans, objectives, and expectations contained in this Item. When used in this quarterly report and in future filings by us with the Securities and Exchange Commission (“SEC”), the words or phrases “expects”, “will likely result”, “will continue”, “is anticipated”, “estimated” or similar expressions are intended to identify “forward-looking statements.” Readers are cautioned not to place undue reliance on such forward-looking statements, each of which speaks only as of the date made. Such statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical results and those presently anticipated or projected, including the risks and uncertainties identified in our annual report on Form 10-K for the fiscal year ended December 31, 2019 (the “2019 Annual Report”) and in this Item 2 of Part I of this quarterly report. Examples of such risks and uncertainties include general economic and business conditions, competition, unexpected changes in technologies and technological advances, the timely development and commercial acceptance of new products and technologies, reliance on key suppliers, reliance on our intellectual property, the outcome of our intellectual property litigation and the ability to obtain adequate financing in the future. We have no obligation to publicly release the results of any revisions which may be made to any forward-looking statements to reflect anticipated events or circumstances occurring after the date of such statements.

#### Corporate Website

We announce investor information, including news and commentary about our business, financial performance and related matters, SEC filings, notices of investor events, and our press and earnings releases, in the investor relations section of our website (http://ir.parkervision.com). Additionally, if applicable, we webcast our earnings calls and certain events we participate in or host with members of the investment community in the investor relations section of our website. Investors and others can receive notifications of new information posted in the investor relations section in real time by signing up for email alerts and/or RSS feeds. Further corporate governance information, including our governance guidelines, Board committee charters, and code of conduct, is also available in the investor relations section of our website under the heading “Corporate Governance.” The content of our website is not incorporated by reference into this Quarterly Report or in any other report or document we file with the SEC, and any references to our website are intended to be inactive textual references only.

#### Overview

We have designed and developed proprietary radio frequency (“RF”) technologies and integrated circuits for use in wireless communication products. We have expended significant financial and other resources to research and develop our RF technologies and to obtain patent protection for those technologies in the United States of America (“U.S.”) and certain foreign jurisdictions. We believe certain patents protecting our proprietary technologies have been broadly infringed by others and therefore the primary focus of our business plan is the enforcement of our intellectual property rights through patent infringement litigation and licensing efforts. We currently have patent enforcement actions ongoing in various U.S. district courts against providers of mobile handsets and providers of smart televisions and other WiFi products and, in certain cases, their chip suppliers, for the infringement of several of our RF patents. We have made significant investments in developing and protecting our technologies, the returns on which are dependent upon the generation of future revenues for realization.

#### Recent Developments

#### Impact of COVID-19

Many states, including Florida, have been under stay-at-home orders since mid-March 2020 in an effort to contain the spread of COVID-19. While our employees currently have the ability and are encouraged to work remotely, school closures and other stay-at-home measures have an impact on employee productivity and attendance. In addition, we have experienced delays in certain deadlines in our patent infringement litigation as a result of court closures, travel bans and stay-at-home measures in Florida as well as other states in which we have ongoing litigation and states in which the defendants to our patent infringement actions have personnel and facilities. In addition, the current economic environment as a result of COVID-19 makes access to debt and equity capital more challenging.

In May 2020, we received approximately $0.2 million in proceeds from an approved loan under the Paycheck Protection Program. Interest will accrue on outstanding principal balance at a rate of 1%, computed on a simple interest basis. The loan principal and accrued interest will be eligible for forgiveness provided that (i) we used the loan proceeds exclusively for allowed costs including payroll, employee group health benefits, rent and utilities and (ii) employee and compensation levels were maintained during the covered period. We believe we will be eligible for forgiveness of all, or a substantial portion of, the loan. If the loan is not forgiven, we will be required to make monthly repayments of approximately $8,000 per month commencing May 1, 2021 and the loan will mature on May 3, 2022, at which time any unpaid principal and accrued interest will be due and payable.

#### Legal Proceedings

Since June 2020, we have filed an aggregate of six patent infringement cases in the Western District of Texas against alleged infringers of certain of our patents. Two cases were filed against Intel and Intel subsequently filed IPR actions against two of the asserted patents. The PTAB has not yet ruled whether to institute a review or dismiss the petitions. The remaining four cases were filed against foreign corporations who manufacture and sell televisions and other devices that incorporate chips manufactured by Realtek and/or MediaTek. The law firm of Goldberg Segalla is representing us on a contingency basis in all of these cases.

In October 2020, our damages expert in *ParkerVision v. Qualcomm* submitted a report concluding that $1.3 billion is the reasonable royalty owed by Qualcomm for their unauthorized use of our technology. The damages amount, along with any additional amounts for interest and enhanced damages for willful infringement will ultimately be determined by the court. Expert discovery concludes in December 2020 and the jury trial commences May 3, 2021in Florida.

#### Sale of Stock with Contingent Payment Rights

From March to September 2020, we received an aggregate of $3.0 million from the sale of equity securities with contingent payment rights. The contingent payment rights entitle the investors to an allocated portion of our share of proceeds from patent-related actions, after taking into account fees and expenses payable to law firms representing us and amounts payable to Brickell.

#### Amendment to Articles of Incorporation

On August 31, 2020, our shareholders approved an amendment to our amended and restated articles of incorporation to increase the number of authorized shares of common stock from 110 million to 140 million. We filed the amendment with the Department of State of the State of Florida on September 2, 2020 and the amendment became effective on September 4, 2020.

#### Liquidity and Capital Resources

We have incurred significant losses from operations and negative operating cash flows in every year since inception, largely as a result of our significant investments in developing and protecting our intellectual property, and have utilized the proceeds from sales of debt and equity securities and contingent funding arrangements with third-parties to fund our operations, including the cost of litigation.

At September 30, 2020, we had cash and cash equivalents of $0.1 million, a working capital deficit of approximately $4.8 million, and an accumulated deficit of approximately $415.0 million. These circumstances raise substantial doubt about our ability to continue to operate as a going concern within one year following the issue date of our condensed consolidated financial statements.

We used cash for operations of approximately $4.2 million and $3.3 million for the nine months ended September 30, 2020 and 2019, respectively. The increase in cash used for operations from 2019 to 2020 is primarily due to increases in payments of out-of-pocket expenses for ongoing litigation that were not covered under existing contingent fee arrangements. For the nine months ended September 30, 2020, we received aggregate net proceeds from the sale of debt and equity securities, including the exercise of outstanding warrants, of approximately $5.5 million compared to approximately $2.7 million in proceeds received for the nine months ended September 30, 2019. We repaid approximately $1.3 million and $0.8 million, respectively in debt obligations during the nine months ended September 30, 2020 and 2019. In addition, we repaid approximately $0.7 million in short-term debt and other accrued expenses with the use of shares of our common stock during the nine months ended September 30, 2020. Despite our recent funding efforts, our resources are not sufficient to meet our short-term liquidity needs and we will be required to seek additional capital.

We are exploring additional financing opportunities for both our short and long-term capital needs. These financing opportunities may include debt, convertible debt, common or preferred equity offerings, or a combination thereof. There can be no assurance that we will be able to consummate a financing transaction or that the terms of such financing will be on terms and conditions that are acceptable.

At September 30, 2020, we had approximately $0.2 million in debt obligations to be paid within twelve months, a decrease of $1.3 million in current debt obligations at December 31, 2019. The decrease in our short-term debt repayment obligations is primarily the result of $1.2 million in repayments under secured and unsecured promissory notes and $0.2 million in repayments of short-term notes with shares of our common stock.

Our ability to meet our short-term liquidity needs, including our debt repayment obligations, is dependent upon (i) our ability to successfully negotiate licensing agreements and/or settlements relating to the use of our technologies by others in excess of our contingent payment obligations to Brickell, legal counsel, and other investors; and (ii) our ability to raise additional capital from the sale of debt or equity securities or other financing arrangements.

Patent enforcement litigation is costly and time-consuming and the outcome is difficult to predict. We expect to continue to invest in the support of our patent enforcement and licensing programs. We expect that revenue generated from patent enforcement actions and/or technology licenses in 2020, if any, after deduction of payment obligations to Brickell, legal counsel, and other investors, may not be sufficient to cover our operating expenses. In the event we do not generate revenues, or other patent-related proceeds, sufficient to cover our operational costs and contingent repayment obligations, we will be required to raise additional working capital through the sale of equity securities or other financing arrangements.

The long-term continuation of our business plan is dependent upon the generation of sufficient revenues from our technologies and/or products to offset expenses and contingent payment obligations. In the event that we do not generate sufficient revenues, we will be required to obtain additional funding through public or private debt or equity financing or contingent fee arrangements and/or reduce operating costs. Failure to generate sufficient revenues, raise additional capital through debt or equity financings or contingent fee arrangements, and/or reduce operating costs will have a material adverse effect on our ability to meet our long-term liquidity needs and achieve our intended long-term business objectives.

#### Results of Operations for Each of the Three and Nine Months Ended September 30, 2020 and 2019

### Revenue and Gross Margin

We reported no licensing revenue for the three or nine-month periods ended September 30, 2020 or 2019. Although we do anticipate licensing revenue and/or settlement gains to result from our licensing and patent enforcement actions, the amount and timing is highly unpredictable and there can be no assurance that we will achieve our anticipated results.

Due to our ceasing the sales of Milo products in the fourth quarter of 2019, we reported no product revenue for the three or nine-month periods ended September 30, 2020. We reported approximately $0.03 and $0.07 million for the three and nine-month periods ended September 30, 2019, from sales of our Milo-branded WiFi products.

### Research and Development Expenses

Subsequent to March 31, 2019, we halted substantially all research and development efforts and, where applicable, repurposed prior engineering resources to support our patent enforcement programs for our Milo sales and support. Research and development expenses for the nine-month period ended September 30, 2019 consist primarily of engineering and related management and support personnel costs; software licensing and support costs, which represent the annual licensing and support maintenance for engineering design and other software tools; and an allocated portion of rent and other overhead costs for our facilities. Personnel costs include share-based compensation which represents the grant date fair value of equity-based awards to our employees which is attributed to expense over the service period of the award.

Our research and development expenses decreased by approximately $0.3 million, or 100.0%, during the nine months ended September 30, 2020 when compared to the same nine-month period in 2019. The decrease is primarily the result of $0.2 million in personnel and related costs being repurposed for selling, general and administrative purposes, including litigation support and Milo sales and support as well as a $0.1 million reduction in research and development personnel costs.

### Selling, General, and Administrative Expenses

Selling, general and administrative expenses consist primarily of litigation fees and expenses, personnel and related costs, including share-based compensation, for executive, board, finance and accounting and technical support for our patent enforcement program, and costs incurred for insurance, outside accounting and legal professional fees, shareholder relations and noncash expenses including amortization and expense recognized in connection with contract amendments.

Our selling, general and administrative expenses decreased by approximately $0.5 million, or 26%, during the three months ended September 30, 2020 when compared to the same period in 2019. This is primarily due to a $0.2 million decrease in litigation expenses resulting from the stay in the Qualcomm and Apple infringement case in Florida, a $0.2 million decrease in personnel costs resulting from personnel changes and attrition, a $0.1 million decrease in rental and other overhead expenses primarily as a result of the down-sizing of our corporate headquarters in July 2019, and a $0.1 million decrease in accounting and other professional fees primarily as a result of a change in accounting firms.

Our selling, general and administrative expenses increased by approximately $3.3 million, or 56%, during the nine months ended September 30, 2020 when compared to the same period in 2019. This increase is primarily the result of the recognition of $2.2 million in noncash expenses recognized upon amendment of equity-related agreements, a $1.3 million increase in litigation expenses primarily related to preparation of the infringement case against Qualcomm and Apple in Florida in early 2020, and a $0.5 million increase in share-based compensation due to executive and Board equity awards granted in August 2019 and the first quarter of 2020. These increases were somewhat offset by a decrease of $0.3 million in board compensation expenses due to the reversal of prior board compensation expense upon the settlement of previously accrued board fees in exchange for equity based awards in 2020 and a decrease of $0.2 million in rent and related overhead due to the down-sizing of our corporate headquarters in July 2019.

### Change in Fair Value of Contingent Payment Obligations

We have elected to measure our secured and unsecured contingent payment obligations at fair value which is based on significant unobservable inputs. We estimated the fair value of our secured contingent payment obligations using a probability-weighted income approach based on the estimated present value of projected future cash outflows using a risk-adjusted discount rate. Increases or decreases in the significant unobservable inputs could result in significant increases or decreases in fair value.

For the nine months ended September 30, 2020, we recorded an increase in the fair value of our secured and unsecured contingent payment obligations of approximately $3.5 million, compared to a decrease of approximately $0.8 million for the nine months ended September 30, 2019. Generally, changes in fair value are a result of changes in estimated amounts and timing of projected future cash flows due to increases in funded amounts, passage of time, and changes in the probabilities based on the status of the funded actions. In addition, in 2020, increases in fair value resulted from the sharp decrease in the risk-free interest rate used in the calculation as a result of the Federal Reserve lowering rates to stimulate economic activity amidst the COVID-19 pandemic.

#### Off-Balance Sheet Transactions, Arrangements and Other Relationships

As of September 30, 2020, we had outstanding warrants to purchase approximately 13.9 million shares of our common stock. The estimated grant date fair value of these warrants of approximately $2.0 million is included in shareholders’ deficit in our condensed consolidated balance sheets. The outstanding warrants have a weighted average exercise price of $0.44 per share and a weighted average remaining life of approximately 3.3 years.

#### Critical Accounting Policies

There have been no changes in accounting policies from those stated in our 2019 Annual Report. We do not expect any newly effective accounting standards to have a material impact on our financial position, results of operations or cash flows when they become effective, other than those described in Note 4 of the interim condensed consolidated financial statements.

## Market risk

As filed, 1,211 characters.

We have a note in the principal amount of $0.02 million payable to Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. (“Mintz”) for outstanding, unpaid attorney’s fees and costs associated with our patent enforcement program. We have been in payment default on the note since November 17, 2019, and accordingly, have accrued interest at the default rate of 12% per annum. Currently, Mintz has not requested acceleration of unpaid principal and interest on the note, nor have they waived the outstanding default. During the nine months ended September 30, 2020, we made payments to Mintz of $1.2 million which we applied to outstanding principal and interest on the Mintz note, leaving an outstanding balance at September 30, 2020 of approximately $0.02 million. Mintz disputes our application of payments against principal and interest on the note rather than against the $3.1 million in outstanding billed and unpaid fees and expenses payable to Mintz that are included in our accounts payable at September 30, 2020. We are in active discussions with Mintz to resolve our outstanding fee dispute. Our total arrearage on the secured note as of November 6, 2020 is $0.02 million which includes default interest.

## Controls and procedures

As filed, 953 characters.

#### Evaluation of Disclosure Controls and Procedures

As of September 30, 2020, our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our “disclosure controls and procedures,” as defined in Rule 13a-15(e) and 15d-15(e) under the Securities and Exchange Act of 1934, as amended (the “Exchange Act”). Based upon this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that these disclosure controls and procedures were effective as of September 30, 2020.

#### Changes in Internal Control Over Financial Reporting

There have been no changes in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) under the Exchange Act that occurred during the last fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 395 characters.

There have been no material changes from the risk factors disclosed in Item 1A of Part I of our Annual Report. In addition to the information in this quarterly report, the risk factors disclosed in our Annual Report should be carefully considered in evaluating our business because such factors may have a significant impact on our business, operating results, liquidity and financial condition.

Filed Nov 16, 2020.
Source: SEC EDGAR, the filing index for accession 0000914139-20-000071. Last ingested by Listed: Nov 11, 2026, 01:56 ET. No prices; not investment advice.
